Dashboard
Manage Tickers

CVRX CVRx, Inc.

Nasdaq cvrx.com


$ 9.68 $ -0.04 (-0.41 %)    

Monday, 10-Nov-2025 15:59:51 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 620.74 $ 0.00 (0 %)
DIA $ 474.13 $ 0.00 (0 %)
SPY $ 680.05 $ 0.00 (0 %)
TLT $ 89.96 $ 0.00 (0 %)
GLD $ 380.64 $ 0.00 (0 %)
$ 9.67
$ 9.86
$ 9.50 x 100
$ 9.93 x 6
-- - --
$ 4.30 - $ 18.55
235,419
na
253.45M
$ 1.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
4 02-18-2025 12-31-2024 10-K
5 11-01-2024 09-30-2024 10-Q
6 08-02-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 02-09-2024 12-31-2023 10-K
9 10-31-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 02-10-2023 12-31-2022 10-K
13 11-04-2022 09-30-2022 10-Q
14 08-01-2022 06-30-2022 10-Q
15 05-02-2022 03-31-2022 10-Q
16 02-22-2022 12-31-2021 10-K
17 11-08-2021 09-30-2021 10-Q
18 08-09-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

canaccord-genuity-maintains-buy-on-cvrx-raises-price-target-to-11
Canaccord Genuity Maintains Buy on CVRx, R...
11/06/2025 19:58:09

Canaccord Genuity analyst William Plovanic maintains CVRx (NASDAQ:CVRX) with a Buy and raises the price target from $9 to $11.

cantor-fitzgerald-maintains-overweight-on-cvrx-raises-price-target-to-13
Cantor Fitzgerald Maintains Overweight on ...
11/06/2025 14:30:02

Cantor Fitzgerald analyst Ross Osborn maintains CVRx (NASDAQ:CVRX) with a Overweight and raises the price target from $11 to...

cvrx-sees-q4-sales-15000m-16000m-vs-15846m-est
CVRx Sees Q4 Sales $15.000M-$16.000M vs $1...
11/05/2025 21:31:43

For the fourth quarter of 2025, the Company expects to report total revenue between $15.0 million and $16.0 million.

cvrx-narrows-fy2025-sales-guidance-from-55000m-57000m-to-55600m-56600m-vs-55980m-est
CVRx Narrows FY2025 Sales Guidance from $5...
11/05/2025 21:31:23

Business OutlookFor the full year of 2025, the Company updated its guidance ranges and now expects:Total revenue between $55.6 ...

cvrx-q3-eps-049-beats-050-estimate-sales-14690m-beat-14157m-estimate
CVRx Q3 EPS $(0.49) Beats $(0.50) Estimate...
11/05/2025 21:30:33

CVRx (NASDAQ:CVRX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.50) by 1.61 ...

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

cantor-fitzgerald-reiterates-overweight-on-cvrx-maintains-11-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/05/2025 12:25:11

Cantor Fitzgerald analyst Ross Osborn reiterates CVRx (NASDAQ:CVRX) with a Overweight and maintains $11 price target.

cvrx-sees-q3-sales-13700m-14700m-vs-14537m-est
CVRx Sees Q3 Sales $13.700M-$14.700M vs $1...
08/04/2025 20:11:45

CVRx (NASDAQ:CVRX) sees Q3 sales of $13.700 million-$14.700 million vs $14.537 million analyst estimate.

cvrx-narrows-fy2025-sales-guidance-from-55000m-58000m-to-55000m-57000m-vs-56086m-est
CVRx Narrows FY2025 Sales Guidance from $5...
08/04/2025 20:11:35

CVRx (NASDAQ:CVRX) narrows FY2025 sales outlook from $55.000 million-$58.000 million to $55.000 million-$57.000 million vs $56....

cvrx-q2-eps-057-misses-053-estimate-sales-13589m-beat-13217m-estimate
CVRx Q2 EPS $(0.57) Misses $(0.53) Estimat...
08/04/2025 20:11:06

CVRx (NASDAQ:CVRX) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.53) by 7.5...

Core News & Articles
Earnings Scheduled For August 4, 2025
08/04/2025 08:32:29

cvrxs-barostim-implant-set-for-45k-medicare-reimbursement-under-proposed-outpatient-rule
CVRx's Barostim Implant Set for $45K Medic...
07/16/2025 11:32:40

CVRx, Inc. (NASDAQ:CVRX) ("CVRx"), a commercial-stage medical device company, announced today that the Centers for Medi...

demystifying-cvrx-insights-from-4-analyst-reviews
Demystifying CVRx: Insights From 4 Analyst...
05/09/2025 18:00:35

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
05/09/2025 17:06:39

piper-sandler-maintains-overweight-on-cvrx-lowers-price-target-to-12
Piper Sandler Maintains Overweight on CVRx...
05/09/2025 14:36:05

Piper Sandler analyst Matt O'Brien maintains CVRx (NASDAQ:CVRX) with a Overweight and lowers the price target from $20 t...

this-national-vision-holdings-analyst-turns-bullish-here-are-top-3-upgrades-for-friday
This National Vision Holdings Analyst Turn...
05/09/2025 13:15:52

this-international-paper-analyst-turns-bearish-here-are-top-5-downgrades-for-friday
This International Paper Analyst Turns Bea...
05/09/2025 12:08:44

dave-to-rally-around-17-here-are-10-top-analyst-forecasts-for-friday
Dave To Rally Around 17%? Here Are 10 Top ...
05/09/2025 11:57:59

jp-morgan-downgrades-cvrx-to-underweight-lowers-price-target-to-7
JP Morgan Downgrades CVRx to Underweight, ...
05/09/2025 11:37:31

JP Morgan analyst Robbie Marcus downgrades CVRx (NASDAQ:CVRX) from Neutral to Underweight and lowers the price target from $...

cvrx-lowers-fy2025-sales-guidance-from-6300m-6500m-to-5500m-5800m-vs-6143m-est
CVRx Lowers FY2025 Sales Guidance from $63...
05/08/2025 20:26:08

CVRx (NASDAQ:CVRX) lowers FY2025 sales outlook from $63.00 million-$65.00 million to $55.00 million-$58.00 million vs $61.43 mi...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION